PEDIATRICS Vol. 75 No. 5 May 1985, pp. 819-826
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Odio, C. M.
Right arrow Articles by Nelson, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Odio, C. M.
Right arrow Articles by Nelson, J. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Comparative Treatment Trial of Augmentin Versus Cefaclor for Acute Otitis Media with Effusion

Carla M. Odio MD1, Helen Kusmiesz RN1, Sharon Shelton BS1, and John D. Nelson MD1

1 From the Department of Pediatrics, The University of Texas Health Science Center at Dallas, Dallas

A total of 150 children with acute otitis media were randomly allocated to treatment with amoxicillin-potassium clavulanate (Augmentin) or with cefaclor. Each drug was given in a daily dosage of approximately 40 mg/kg in three divided doses for ten days. Tympanocentesis done before treatment yielded specimens that contained pneumococcus or Haemophilus sp or both in 67% of specimens. Viridans group streptococci were isolated from 10% of specimens and Branhamella catarrhalis from 6%. Patients were scheduled for followup examinations at midtreatment, end of therapy, and at 30, 60, and 90 days. Of the 150 children, 130 were evaluable. Five of 60 patients (8%) treated with cefaclor were considered therapeutic failures because of persistent purulent drainage and isolation of the original pathogen or suprainfection. There were no failures among patients treated with Augmentin (P = .019). Rates of relapse, recurrent acute otitis media with effusion, and persistent middle ear effusion were comparable in the two groups of patients. Diaper rash, or loose stools, or both were significantly more common in children treated with Augmentin (34%) than in those taking cefaclor (12%), but in no case was it necessary to discontinue medication because of these mild side effects (P = .002). Cefaclor therapy was discontinued in one patient because of severe abdominal pain and vomiting. In this study, treatment with Augmentin was superior to treatment with cefaclor in the acute phase of acute otitis media with effusion, but Augmentin produced more adverse effects. The rates of persistent middle ear effusion and recurrent acute otitis media with effusion were comparable with the two regimens.

Key Words: otitis media with effusion • Augmentin • cefaclor • amoxicillin • clavulanic acid

Submitted on January 25, 1984
Accepted on April 27, 1984


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
F. Salvo, G. Polimeni, U. Moretti, A. Conforti, R. Leone, O. Leoni, D. Motola, G. Dusi, and A. P. Caputi
Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy
J. Antimicrob. Chemother., July 1, 2007; 60(1): 121 - 126.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
S. C Hogan, K. J Stratford, and D. R Moore
Duration and recurrence of otitis media with effusion in children from birth to 3 years: prospective study using monthly otoscopy and tympanometry
BMJ, February 1, 1997; 314(7077): 350 - 350.
[Abstract] [Full Text]

Home page
 DTBHome page
Augmentin reconsidered
DTB, October 1, 1996; 34(10): 76 - 78.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
T. E. Liston
Management of Otitis Media: A Review
Clinical Pediatrics, October 1, 1995; 34(10): 542 - 548.
[PDF]